Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ZMA-001 by Zymedi for Pulmonary Arterial Hypertension: Likelihood of Approval
ZMA-001 is under clinical development by Zymedi and currently in Phase I for Pulmonary Arterial Hypertension. According to GlobalData, Phase...